Concepedia

Biochemistry and Pharmacology of Novel Anthranilic Acid Derivatives Activating Heme-Oxidized Soluble Guanylyl Cyclase

Ursula Schindler, Hartmut Strobel, Karl Schönafinger, Wolfgang Linz, Matthias Löhn, Piero A. Martorana, Hartmut Rütten, Peter W. Schindler, Andreas Büsch, Michael Sohn,

Molecular Pharmacology · 2005 · 97 citations · 23 references

DOI

Concepts

References

23

Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.

Astrid Schrammel, Sönke Behrends, Kurt Schmidt et al. · Molecular Pharmacology · 1996 · 358 citations

, , +8

NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

Johannes‐Peter Stasch, Péter Schmidt, Cristina Alonso‐Alija et al. · British Journal of Pharmacology · 2002 · 312 citations · Full text

, , +14

Vasodilator-Stimulated Phosphoprotein Serine 239 Phosphorylation as a Sensitive Monitor of Defective Nitric Oxide/cGMP Signaling and Endothelial Dysfunction

Matthias Oelze, Hanke Mollnau, Nina Hoffmann et al. · Circulation Research · 2000 · 257 citations

, , +16

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase.

Barbara J. Wedel, P. Humbert, Christian Harteneck et al. · Proceedings of the National Academy of Sciences · 1994 · 253 citations

, , +15

Effects of Long-Term Nitroglycerin Treatment on Endothelial Nitric Oxide Synthase (NOS III) Gene Expression, NOS III–Mediated Superoxide Production, and Vascular NO Bioavailability

Thomas Münzel, Huige Li, Hanke Mollnau et al. · Circulation Research · 2000 · 236 citations · Full text

, , +13